9280
Comment:
|
← Revision 85 as of 2024-11-09 04:23:30 ⇥
12715
|
Deletions are marked like this. | Additions are marked like this. |
Line 4: | Line 4: |
||<style="text-align:center;">{{attachment:UofManitoba.png||width=150}}||[[ http://umanitoba.ca/ |University of Manitoba]]||Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes <<BR>><<BR>>Pl: Kevin Coombs||2020-2021|| ||<style="text-align:center;">{{attachment:nrc.png||width=150}}||[[ https://nrc.canada.ca/en |National Research Council Canada]]||AI for Precision Discovery on Associations in Biological Systems <<BR>><<BR>>Pl: Xiaojian Shao, Youlian Pan ||2020-2021|| ||<style="text-align:center;">{{attachment:CZI.png||width=150}}||[[ https://chanzuckerberg.com/ |Chan Zuckerberg Initiative]]||A reference cell atlas of human liver diversity of a lifespan ||2019-2021|| ||<style="text-align:center;">{{attachment:cfref.png||width=150}}||[[ https://www.cfref-apogee.gc.ca/home-accueil-eng.aspx |Canada First Research Excellence Fund]]||Stem cell based approaches to endogenous repair of brain and skeletal muscle <<BR>><<BR>>Pl: Freda Miller ||2019-2020|| |
||<style="text-align: center;">{{attachment:CIFAR.jpg||width=150}}||[[https://cifar.ca/|CIFAR]]||The Multiscale Human <<BR>><<BR>>Funding acknowledgement: Gary Bader is a CIFAR Fellow in the MacMillan Multiscale Human Program.<<BR>> PI: Gary Bader||2023-2028|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]]||Cytoscape: An Ecosystem for Network Genomics <<BR>><<BR>> PI: Trey Ideker||2022-2027|| ||<style="text-align:center;">{{attachment:CIHR.jpg}}||[[ http://www.cihr-irsc.gc.ca/|Canadian Institutes of Health Research]] ||Cellular ecosystem modelling of liver cancer <<BR>><<BR>>PI: Gary Bader||2022-2027|| ||<style="text-align:center;">{{attachment:NSERC.png||width=200}}||[[http://www.nserc-crsng.gc.ca/|Natural Sciences and Engineering Research Council of Canada]]||Mathematical modelling of tissue development <<BR>><<BR>>Pl: Gary Bader||2022-2027|| ||<style="text-align: center;">{{attachment:CZI.png||width=150}}||[[ https://chanzuckerberg.com/ |Chan Zuckerberg Initiative]]||Deciphering the Cellular Ecosystem of Primary Sclerosing Cholangitis <<BR>><<BR>> PI: Sonya MacParland||2022-2025|| ||<style="text-align: center;">{{attachment:Brain.jpg||width=150}}||[[https://braincanada.ca/|Brain Canada Foundation]]||[[https://www.pmgenomics.ca/pmgenomics/bsci.html|The Brain Single Cell Initiative]] <<BR>><<BR>> PI: Trevor Pugh||2022-2025|| ||<style="text-align:center;">{{attachment:OICR.jpeg||width=150}}||[[ https://oicr.on.ca/ |Ontario Institute for Cancer Research]]||Probing the developmental origins of pediatric cerebellar brain cancers using single cell profiling <<BR>><<BR>>PI: Lincoln Stein||2021-2026|| ||<style="text-align:center;">{{attachment:CZI.png||width=200}}||[[https://chanzuckerberg.com/ |Chan Zuckerberg Initiative]]||Single Cell Atlas of Human Pediatric Livers Across Diverse Ancestry <<BR>><<BR>>PI: Alan Mullen||2021-2024|| ||<style="text-align:center;">{{attachment:NewTerryFox.jpg||width=250}}||[[http://www.tfri.ca/|The Terry Fox Research Institute]]|| The Terry Fox New Frontiers Program Project Grant in the Determinants of stemness that underlie high risk or relapse disease <<BR>><<BR>>Pl: John Dick||2020-2026|| ||<style="text-align:center;">{{attachment:CCS.PNG||width=150}}||[[ https://www.cancer.ca/en/get-involved/events-and-participation/home-march/?region=on |Canadian Cancer Society]]||Reimagining glioblastoma as a consequence of aberrant neural tissue repair <<BR>><<BR>>Pl: Peter Dirks||2020-2024|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]]||[[http://nrnb.org/|National Resource for Network Biology (NRNB)]], PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2010-2025|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]]||[[http://www.cytoscape.org/|Cytoscape: A Modeling Platform for Biomolecular Networks]]<<BR>><<BR>>Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Human Genome Research Institute (NHGRI) under award number HG009979.<<BR>><<BR>>Cytoscape user support, education and new initiatives are supported by the National Resource for Network Biology (NRNB) under award numbers P41 RR031228 and GM103504.<<BR>><<BR>>PIs: Trey Ideker, Gary Bader.||2004-2027|| ||<style="text-align:center;">{{attachment:CIHR.jpg||width=150}}||[[ http://umanitoba.ca/ |University of Manitoba]]||Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes <<BR>><<BR>>Pl: Kevin Coombs||2020-2021|| ||<style="text-align:center;">{{attachment:nrc.png||width=150}}||[[ https://nrc.canada.ca/en |National Research Council Canada]]||AI for Precision Discovery on Associations in Biological Systems <<BR>><<BR>>Spon Ref: AI4D-109-1<<BR>><<BR>>Pl: Xiaojian Shao, Youlian Pan ||2020-2021|| ||<style="text-align:center;">{{attachment:CZI.png||width=150}}||[[ https://chanzuckerberg.com/ |Chan Zuckerberg Initiative]]||A reference cell atlas of human liver diversity over a lifespan <<BR>><<BR>> Acknowledgement text "This project has been made possible in part by a grant from the Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation."<<BR>><<BR>> PI: Alan Mullen ||2019-2021|| ||<style="text-align:center;">{{attachment:cfref.png||width=150}}||[[ https://www.cfref-apogee.gc.ca/home-accueil-eng.aspx |Canada First Research Excellence Fund]]||Stem cell based approaches to endogenous repair of brain and skeletal muscle <<BR>><<BR>> Spon Ref::MBDC2-2019-02 <<BR>><<BR>>PI's: Freda Miller, Alison McGuigan, Peter Zandstra, Penny Gilbert, Sidhartha Goyal, Cindi Morshead, Yun Li, David Kaplan ||2019-2020|| |
Line 12: | Line 24: |
||<style="text-align:center;">{{attachment:CFI.png||width=150}}||[[ https://www.innovation.ca/ |Canada Foundation for Innovation]]||The Cancer Genome Collaboratory <<BR>><<BR>>Pl: Lincoln Stein <<BR>><<BR>>The authors wish to acknowledge the funding support of the Canada Foundation for Innovation Cyberinfrastructure Initiative, the Ontario Research Fund, BC Knowledge Development Fund and the Ministère de l'Économie, de la Science et l'Innovation for 'The Cancer Genome Collaboratory' project||2016-2022|| | |
Line 13: | Line 26: |
||<style="text-align: center;">{{attachment:cfref.png||width=150}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). <<BR>><<BR>> PI: Molly Shoichet.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019|| ||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). <<BR>><<BR>> PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019|| ||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). <<BR>><<BR>> PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”|| 2016-2019|| |
||<style="text-align: center;">{{attachment:cfref.png||width=170}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). <<BR>><<BR>> PI: Molly Shoichet.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019|| ||<style="text-align: center;">{{attachment:cfref.png||width=150}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). <<BR>><<BR>> PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019|| ||<style="text-align: center;">{{attachment:cfref.png||width=150}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). <<BR>><<BR>> PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”|| 2016-2019|| |
Line 23: | Line 36: |
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]]||[[http://nrnb.org/|National Resource for Network Biology (NRNB)]], PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2012-2017|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]]||[[http://www.cytoscape.org/|Cytoscape: A Modeling Platform for Biomolecular Networks]]<<BR>><<BR>>Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Human Genome Research Institute (NHGRI) under award number HG009979.<<BR>><<BR>>Cytoscape user support, education and new initiatives are supported by the National Resource for Network Biology (NRNB) under award numbers P41 RR031228 and GM103504.<<BR>><<BR>>PIs: Trey Ideker, Gary Bader.||2009-2017|| |
Funding Agency |
Title |
Grant Period |
|
The Multiscale Human |
2023-2028 |
||
Cytoscape: An Ecosystem for Network Genomics |
2022-2027 |
||
Cellular ecosystem modelling of liver cancer |
2022-2027 |
||
Mathematical modelling of tissue development |
2022-2027 |
||
Deciphering the Cellular Ecosystem of Primary Sclerosing Cholangitis |
2022-2025 |
||
The Brain Single Cell Initiative |
2022-2025 |
||
Probing the developmental origins of pediatric cerebellar brain cancers using single cell profiling |
2021-2026 |
||
Single Cell Atlas of Human Pediatric Livers Across Diverse Ancestry |
2021-2024 |
||
The Terry Fox New Frontiers Program Project Grant in the Determinants of stemness that underlie high risk or relapse disease |
2020-2026 |
||
Reimagining glioblastoma as a consequence of aberrant neural tissue repair |
2020-2024 |
||
National Resource for Network Biology (NRNB), PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader. |
2010-2025 |
||
U.S. NIH via National Institute of General Medical Sciences (NIGMS) |
Cytoscape: A Modeling Platform for Biomolecular Networks |
2004-2027 |
|
Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes |
2020-2021 |
||
AI for Precision Discovery on Associations in Biological Systems |
2020-2021 |
||
A reference cell atlas of human liver diversity over a lifespan |
2019-2021 |
||
Stem cell based approaches to endogenous repair of brain and skeletal muscle |
2019-2020 |
||
Investigating how age-related clonal hematopoiesis drives HSC stemness properties ane how this leads to inflammatory disease of the heart |
2019-2020 |
||
Development of novel cell and tissue therapies to treat liver failure |
2019-2020 |
||
Cellular and Genetic Heterogeneity as a Therapeutic Hurdle and Opportunity for Ontarians with Brain Cancer (Operating Grant) |
2017-2021 |
||
Acute Leukemia Translational Initiative (Operating Grant) |
2017-2021 |
||
The Cancer Genome Collaboratory |
2016-2022 |
||
Cell and tissue communication networks |
2016-2021 |
||
Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). |
2016-2019 |
||
Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). |
2016-2019 |
||
Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). |
2016-2019 |
||
From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant) |
2015-2022 |
||
Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) |
2015-2020 |
||
A human binary interactome reference map by 2020 (Operational sub-grant:U41-HG001715-18). |
2015-2018 |
||
Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) |
2015-2019 |
||
The Cancer Genome Collaboratory (Operating Grant: Discovery Frontiers) |
2014-2018 |
||
Cancer stem cell program (Operating Grant) |
2013-2017 |
||
Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer (Operating Sub-Grant) |
2013-2017 |
||
U.S. NIH via National Human Genome Research Institute (NHGRI) |
Pathway Commons Research resource for biological pathways. |
2008-2018 |
|
A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324) |
2007-2017 |
||
Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research (Operating Sub-Grant: 69119295) |
2006-2017 |